+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Multiplex Biomarker Imaging Market by Application, by Imaging Techniques Assay, Tissue Microarray Assay, Immunohistochemistry Assay, Fluorescent in the Situ Hybridization Assay, and Toponome Imaging System, and by End-User

  • ID: 4853117
  • Report
  • September 2018
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

The report covers forecast and analysis for the multiplex biomarker imaging market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the multiplex biomarker imaging market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the multiplex biomarker imaging market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the multiplex biomarker imaging market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein application, imaging techniques, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the multiplex biomarker imaging market by segmenting the market based on application, imaging techniques, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Global multiplex biomarker imaging market is divided into its application, imaging techniques, and end-user. On the basis of the application, the market is divided into drug safety, oncology studies, and genetic characterization studies. 

Based on imaging techniques multiplex biomarker imaging market is categorized into immunofluorescence (IF) assay, tissue microarray (TMA) assay, immunohistochemistry (IHC) assay, fluorescent in the situ hybridization (FISH) assay, and toponome imaging system (TIS). 

On the basis of the end user, the multiplex biomarker imaging market is segregated as research institutes government & private, clinical labs, and pharmaceutical & biotechnology.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for multiplex biomarker imaging based on individual segment and application in all the regions and countries.

The report also includes detailed profiles of end players such as Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam Plc., US Biomax Inc., Merck KGaA, ToposNomos Ltd., MicroConstants, Inc., Aushon BioSystems Ltd., Ventana Medical Systems, Inc., Leica Biosystems Nussloch GmbH, Illumina Inc., and others.

This report segments the global multiplex biomarker imaging market as follows:

Global Multiplex Biomarker Imaging Market: By Application

  • Drug Safety
  • Oncology Studies 
  • Genetic Characterization Studies 

Global Multiplex Biomarker Imaging Market: By Imaging Techniques

  • Immuno Fluorescence (IF) Assay
  • Tissue Microarray (TMA) Assay
  • Immunohistochemistry (IHC) Assay
  • Fluorescent in the Situ Hybridization (FISH) Assay
  • Toponome Imaging System (TIS)

Global Multiplex Biomarker Imaging Market: By End User

  • Research Institutes Government & Private
  • Clinical Labs
  • Pharmaceutical & Biotechnology

Global Multiplex Biomarker Imaging Market: By Region

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • The Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global multiplex biomarker imaging market, 2015 - 2024 (USD Million)
    • 2.2. Global multiplex biomarker imaging market : Snapshot
  • Chapter 3. Global Multiplex Biomarker Imaging- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global multiplex biomarker imaging market drivers: Impact analysis
      • 3.2.2. Increasing cancer and tumor-related cases
      • 3.2.3. Cost effective in nature
      • 3.2.4. Provides better results of the analysis which includes thousands of tissue in the single turn
    • 3.3. Market Restraints
      • 3.3.1. Stringent policies of the government
      • 3.3.2. Complex process
      • 3.3.3. Ethical issue
    • 3.4. Opportunities
      • 3.4.1. Technique that has the potential for the anticancer drug discovery
      • 3.4.2. Growing healthcare end-user offers huge potential for multiplex biomarker imaging
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by application
      • 3.6.2. Market attractiveness analysis, by imaging techniques
      • 3.6.3. Market attractiveness analysis, by end use
  • Chapter 4. Global Multiplex Biomarker Imaging Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global multiplex biomarker imaging market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  • Chapter 5. Global Multiplex Biomarker Imaging Market - Application Segment Analysis
    • 5.1. Global multiplex biomarker imaging market: application overview
      • 5.1.1. Global multiplex biomarker imaging market revenue share, by application, 2018 and 2024
    • 5.2. Drug Safety
      • 5.2.1. Global multiplex biomarker imaging market for drug safety, 2015 - 2024 (USD Million)
    • 5.3. Oncology Studies
      • 5.3.1. Global multiplex biomarker imaging market for oncology studies, 2015 - 2024 (USD Million)
    • 5.4. Genetic Characterization Studies
      • 5.4.1. Global multiplex biomarker imaging market for genetic characterization studies, 2015 - 2024 (USD Million)
  • Chapter 6. Global Multiplex Biomarker Imaging Market - Imaging Techniques Segment Analysis
    • 6.1. Global multiplex biomarker imaging market: imaging techniques overview
      • 6.1.1. Global multiplex biomarker imaging market revenue share, by imaging techniques, 2018 and 2024
    • 6.2. Immuno Fluorescence (IF) Assay
      • 6.2.1. Global multiplex biomarker imaging market for immunofluorescence (IF) assay, 2015 - 2024 (USD Million)
    • 6.3. Tissue Microarray (TMA) Assay
      • 6.3.1. Global multiplex biomarker imaging market for tissue microarray (TMA) assay, 2015 - 2024 (USD Million)
    • 6.4. Immunohistochemistry (IHC) Assay
      • 6.4.1. Global multiplex biomarker imaging market for immunohistochemistry (IHC) assay, 2015 - 2024 (USD Million)
    • 6.5. Fluorescent in the Situ Hybridization (FISH) Assay
      • 6.5.1. Global multiplex biomarker imaging market for fluorescent in the situ hybridization (fish) assay, 2015 - 2024 (USD Million)
    • 6.6. Toponome Imaging System (TIS)
      • 6.6.1. Global multiplex biomarker imaging market toponome imaging system (TIS), 2015 - 2024 (USD Million)
  • Chapter 7. Global Multiplex Biomarker Imaging Market - End-User Segment Analysis
    • 7.1. Global multiplex biomarker imaging market: End User overview
      • 7.1.1. Global multiplex biomarker imaging market revenue share, by end user, 2018 and 2024
    • 7.2. Research Institutes Government & Private
      • 7.2.1. Global multiplex biomarker imaging market for research institutes government & private, 2015 - 2024 (USD Million)
    • 7.3. Clinical Labs
      • 7.3.1. Global multiplex biomarker imaging market for clinical labs , 2015 - 2024 (USD Million)
    • 7.4. Pharmaceutical & Biotechnology
      • 7.4.1. Global multiplex biomarker imaging market for pharmaceutical & biotechnology, 2015 - 2024 (USD Million)
  • Chapter 8. Global Multiplex Biomarker Imaging Market - Regional Segment Analysis
    • 8.1. Global multiplex biomarker imaging market: regional overview
      • 8.1.1. Global multiplex biomarker imaging market revenue share, by region, 2018 and 2024
      • 8.1.2. North America
        • 8.1.2.1. North America multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.1.2.2. North America multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.1.2.3. North America multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.1.3. The U.S.
        • 8.1.3.1. The U.S. multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.1.3.2. The U.S. multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.1.3.3. The U.S. multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.1.4. Canada
        • 8.1.4.1. Canada multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.1.4.2. Canada multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.1.4.3. Canada multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
    • 8.2. Europe
      • 8.2.1. Europe multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
      • 8.2.2. Europe multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
      • 8.2.3. Europe multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.2.4. U.K.
        • 8.2.4.1. U.K. multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.2.4.2. U.K. multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.2.4.3. U.K. multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.2.5. Germany
        • 8.2.5.1. Germany multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.2.5.2. Germany multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.2.5.3. Germany multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.2.6. France
        • 8.2.6.1. France multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.2.6.2. France multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.2.6.3. France multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.2.7. Rest of Europe
        • 8.2.7.1. Rest of Europe multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.2.7.2. Rest of Europe multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.2.7.3. Rest of Europe multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
    • 8.3. Asia Pacific
      • 8.3.1. Asia Pacific multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
      • 8.3.2. Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
      • 8.3.3. Asia Pacific multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.3.4. China
        • 8.3.4.1. China multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.3.4.2. China multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.3.4.3. China multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.3.5. Japan
        • 8.3.5.1. Japan multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.3.5.2. Japan multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.3.5.3. Japan multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.3.6. India
        • 8.3.6.1. India multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.3.6.2. India multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.3.6.3. India multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.3.7. Rest of Asia Pacific
        • 8.3.7.1. Rest of Asia Pacific multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.3.7.2. Rest of Asia Pacific multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.3.7.3. Rest of Asia Pacific multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
    • 8.4. Latin America
      • 8.4.1. Latin America multiplex biomarker imaging market revenue, by application, 2015 - 2024(USD Million)
      • 8.4.2. Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
      • 8.4.3. Latin America multiplex biomarker imaging market revenue, by end user, 2015 - 2024(USD Million)
      • 8.4.4. Brazil
        • 8.4.4.1. Brazil multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.4.4.2. Brazil multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.4.4.3. Brazil multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
      • 8.4.5. Rest of Latin America
        • 8.4.5.1. Rest of Latin America multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
        • 8.4.5.2. Rest of Latin America multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
        • 8.4.5.3. Rest of Latin America multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
    • 8.5. The Middle East and Africa
      • 8.5.1. The Middle East and Africa multiplex biomarker imaging market revenue, by application, 2015 - 2024 (USD Million)
      • 8.5.2. The Middle East and Africa multiplex biomarker imaging market revenue, by imaging techniques, 2015 - 2024 (USD Million)
      • 8.5.3. The Middle East and Africa multiplex biomarker imaging market revenue, by end user, 2015 - 2024 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. Thermo Fisher Scientific
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. PerkinElmer Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Bio-Rad Laboratories, Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Abcam Plc.,
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. US Biomax Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Merck KGaA
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. ToposNomos Ltd.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. MicroConstants, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Aushon BioSystems Ltd.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Ventana Medical Systems, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. Leica Biosystems Nussloch GmbH
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
    • 9.12. Illumina Inc.
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product portfolio
      • 9.12.4. Business strategy
      • 9.12.5. Recent developments
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll